Daniel Gruener, MD
Daniel Gruener, MD
CRI Lifetree
Director of Pain Research and Primary Investigator for CRI Lifetree in Philadelphia (headquarters in Mount Laurel, NJ, 08054)
2040 Shadywood Circle Huntingdon Valley, Pa19006
Huntingdon Valley
USA
19006
Papers:
16.1
Methylphenidate Hydrochloride Modified Release for Adults with ADHD: A 40-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy, and Safety Study
16.2
Methylphenidate Hydrochloride Modified Release in Adults with ADHD: Self-Rated, Observer-Rated, and Physician-Rated Assessments Show Consistently Significant Improvement Compared to Placebo